GALECTIN THERAPEUTICS INC. Net Income (Loss) Available to Common Stockholders, Basic
GALECTIN THERAPEUTICS INC. (GALT) reported Net Income (Loss) Available to Common Stockholders, Basic of -$9.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-14
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$9.18M.
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$5.07M.
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$5.56M.
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$8.22M.
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$30.97M.
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$47.20M.
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$44.80M.
- GALECTIN THERAPEUTICS INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$38.87M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 132 month | Net Income (Loss) Available to Common Stockholders, Basic 135 month | Net Income (Loss) Available to Common Stockholders, Basic 138 month | Net Income (Loss) Available to Common Stockholders, Basic 141 month | Net Income (Loss) Available to Common Stockholders, Basic 144 month | Net Income (Loss) Available to Common Stockholders, Basic 147 month | Net Income (Loss) Available to Common Stockholders, Basic 150 month | Net Income (Loss) Available to Common Stockholders, Basic 153 month | Net Income (Loss) Available to Common Stockholders, Basic 156 month | Net Income (Loss) Available to Common Stockholders, Basic 159 month | Net Income (Loss) Available to Common Stockholders, Basic 162 month | Net Income (Loss) Available to Common Stockholders, Basic 165 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.18M 10-Q · filed 2026-08-14 | -$14.24M 10-Q · filed 2026-08-14 | -$19.80M derived: sum of 3 quarters · filed 2026-08-14 | -$28.03M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2026-03-31 | -$5.07M 10-Q · filed 2026-05-15 | -$10.63M derived: sum of 2 quarters · filed 2026-05-15 | -$18.85M derived: sum of 3 quarters · filed 2026-05-15 | -$26.44M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-12-31 | -$5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$13.79M derived: sum of 2 quarters · filed 2026-03-31 | -$21.37M derived: sum of 3 quarters · filed 2026-08-14 | -$30.97M 10-K · filed 2026-03-31 | ||||||||||||||
| 2025-09-30 | -$8.22M 10-Q · filed 2025-11-14 | -$15.81M derived: sum of 2 quarters · filed 2026-08-14 | -$25.41M 10-Q · filed 2025-11-14 | -$37.44M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-06-30 | -$7.58M 10-Q · filed 2026-08-14 | -$17.19M 10-Q · filed 2026-08-14 | -$29.22M derived: sum of 3 quarters · filed 2026-08-14 | -$40.46M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-03-31 | -$9.61M 10-Q · filed 2026-05-15 | -$21.64M derived: sum of 2 quarters · filed 2026-05-15 | -$32.87M derived: sum of 3 quarters · filed 2026-05-15 | -$45.31M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||
| 2024-12-31 | -$12.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$23.27M derived: sum of 2 quarters · filed 2026-03-31 | -$35.70M derived: sum of 3 quarters · filed 2026-03-31 | -$47.20M 10-K · filed 2026-03-31 | ||||||||||||||
| 2024-09-30 | -$11.24M 10-Q · filed 2025-11-14 | -$23.67M derived: sum of 2 quarters · filed 2025-11-14 | -$35.17M 10-Q · filed 2025-11-14 | -$45.23M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||||
| 2024-06-30 | -$12.44M 10-Q · filed 2025-08-14 | -$23.93M 10-Q · filed 2025-08-14 | -$33.99M derived: sum of 3 quarters · filed 2025-08-14 | -$48.03M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||
| 2024-03-31 | -$11.50M 10-Q · filed 2025-05-15 | -$21.56M derived: sum of 2 quarters · filed 2025-05-15 | -$35.60M derived: sum of 3 quarters · filed 2025-05-15 | -$44.77M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||
| 2023-12-31 | -$10.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$24.10M derived: sum of 2 quarters · filed 2025-03-31 | -$33.28M derived: sum of 3 quarters · filed 2025-03-31 | -$44.80M 10-K · filed 2025-03-31 | ||||||||||||||
| 2023-09-30 | -$14.04M 10-Q · filed 2024-11-14 | -$23.22M derived: sum of 2 quarters · filed 2024-11-14 | -$34.74M 10-Q · filed 2024-11-14 | -$45.44M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||||
| 2023-06-30 | -$9.18M 10-Q · filed 2024-08-13 | -$20.70M 10-Q · filed 2024-08-13 | -$31.40M derived: sum of 3 quarters · filed 2024-08-13 | -$39.98M derived: sum of 4 quarters · filed 2024-08-13 | ||||||||||||||
| 2023-03-31 | -$11.53M 10-Q · filed 2024-05-15 | -$22.23M derived: sum of 2 quarters · filed 2024-05-15 | -$30.81M derived: sum of 3 quarters · filed 2024-05-15 | -$40.48M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||||
| 2022-12-31 | -$10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$19.28M derived: sum of 2 quarters · filed 2024-03-29 | -$28.96M derived: sum of 3 quarters · filed 2024-03-29 | -$38.87M 10-K · filed 2024-03-29 | ||||||||||||||
| 2022-09-30 | -$8.58M 10-Q · filed 2023-11-13 | -$18.26M derived: sum of 2 quarters · filed 2023-11-13 | -$28.17M 10-Q · filed 2023-11-13 | -$35.46M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||||
| 2022-06-30 | -$9.68M 10-Q · filed 2023-08-14 | -$19.59M 10-Q · filed 2023-08-14 | -$26.88M derived: sum of 3 quarters · filed 2023-08-14 | -$35.44M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||||
| 2022-03-31 | -$9.92M 10-Q · filed 2023-05-15 | -$17.20M derived: sum of 2 quarters · filed 2023-05-15 | -$25.76M derived: sum of 3 quarters · filed 2023-05-15 | -$34.27M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||||
| 2021-12-31 | -$7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$15.85M derived: sum of 2 quarters · filed 2023-03-30 | -$24.36M derived: sum of 3 quarters · filed 2023-03-30 | -$30.70M 10-K · filed 2023-03-30 | ||||||||||||||
| 2021-09-30 | -$8.56M 10-Q · filed 2022-11-14 | -$17.07M derived: sum of 2 quarters · filed 2022-11-14 | -$23.41M 10-Q · filed 2022-11-14 | -$31.33M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||||
| 2021-06-30 | -$8.51M 10-Q · filed 2022-08-15 | -$14.85M 10-Q · filed 2022-08-15 | -$22.77M derived: sum of 3 quarters · filed 2022-08-15 | -$28.73M derived: sum of 4 quarters · filed 2022-08-15 | ||||||||||||||
| 2021-03-31 | -$6.34M 10-Q · filed 2022-05-16 | -$14.26M derived: sum of 2 quarters · filed 2022-05-16 | -$20.21M derived: sum of 3 quarters · filed 2022-05-16 | -$26.39M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||||
| 2020-12-31 | -$7.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$13.87M derived: sum of 2 quarters · filed 2022-03-31 | -$20.05M derived: sum of 3 quarters · filed 2022-03-31 | -$23.60M 10-K · filed 2022-03-31 | ||||||||||||||
| 2020-09-30 | -$5.96M 10-Q · filed 2021-11-15 | -$12.13M derived: sum of 2 quarters · filed 2021-11-15 | -$15.69M 10-Q · filed 2021-11-15 | -$20.89M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||||
| 2020-06-30 | -$6.18M 10-Q · filed 2021-08-16 | -$9.73M 10-Q · filed 2021-08-16 | -$14.93M derived: sum of 3 quarters · filed 2021-08-16 | -$17.75M derived: sum of 4 quarters · filed 2021-08-16 | ||||||||||||||
| 2020-03-31 | -$3.55M 10-Q · filed 2021-05-17 | -$8.75M derived: sum of 2 quarters · filed 2021-05-17 | -$11.57M derived: sum of 3 quarters · filed 2021-05-17 | -$14.64M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||||
| 2019-12-31 | -$5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$8.02M derived: sum of 2 quarters · filed 2021-03-31 | -$11.09M derived: sum of 3 quarters · filed 2021-03-31 | -$20.18M 10-K · filed 2021-03-31 | ||||||||||||||
| 2019-09-30 | -$2.82M 10-Q · filed 2020-11-09 | -$5.88M derived: sum of 2 quarters · filed 2020-11-09 | -$14.98M 10-Q · filed 2020-11-09 | -$18.33M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||||
| 2019-06-30 | -$3.06M 10-Q · filed 2020-08-10 | -$12.16M 10-Q · filed 2020-08-10 | -$15.51M derived: sum of 3 quarters · filed 2020-08-10 | -$18.55M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||
| 2019-03-31 | -$9.09M 10-Q · filed 2020-05-11 | -$12.44M derived: sum of 2 quarters · filed 2020-05-11 | -$15.49M derived: sum of 3 quarters · filed 2020-05-11 | -$19.60M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||||
| 2018-12-31 | -$3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$6.39M derived: sum of 2 quarters · filed 2020-03-16 | -$10.50M derived: sum of 3 quarters · filed 2020-03-16 | -$15.05M 10-K · filed 2020-03-16 | ||||||||||||||
| 2018-09-30 | -$3.05M 10-Q · filed 2019-11-12 | -$7.15M derived: sum of 2 quarters · filed 2019-11-12 | -$11.70M 10-Q · filed 2019-11-12 | -$14.48M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||
| 2018-06-30 | -$4.11M 10-Q · filed 2019-08-09 | -$8.65M 10-Q · filed 2019-08-09 | -$11.44M derived: sum of 3 quarters · filed 2019-08-09 | -$16.10M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||||
| 2018-03-31 | -$4.54M 10-Q · filed 2019-05-10 | -$7.33M derived: sum of 2 quarters · filed 2019-05-10 | -$11.99M derived: sum of 3 quarters · filed 2019-05-10 | -$16.80M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||||
| 2017-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$7.45M derived: sum of 2 quarters · filed 2019-03-06 | -$12.26M derived: sum of 3 quarters · filed 2019-03-06 | -$17.47M 10-K · filed 2019-03-06 | ||||||||||||||
| 2017-09-30 | -$4.66M 10-Q · filed 2018-11-13 | -$9.47M derived: sum of 2 quarters · filed 2018-11-13 | -$14.68M 10-Q · filed 2018-11-13 | -$19.55M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||||||
| 2017-06-30 | -$4.81M 10-Q · filed 2018-08-14 | -$10.02M 10-Q · filed 2018-08-14 | -$14.88M derived: sum of 3 quarters · filed 2018-08-14 | -$19.53M derived: sum of 4 quarters · filed 2018-08-14 | ||||||||||||||
| 2017-03-31 | -$5.21M 10-Q · filed 2018-05-11 | -$10.07M derived: sum of 2 quarters · filed 2018-05-11 | -$14.72M derived: sum of 3 quarters · filed 2018-05-11 | -$20.55M derived: sum of 4 quarters · filed 2018-05-11 | ||||||||||||||
| 2016-12-31 | -$4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$9.51M derived: sum of 2 quarters · filed 2018-03-29 | -$15.34M derived: sum of 3 quarters · filed 2018-03-29 | -$22.35M 10-K · filed 2018-03-29 | ||||||||||||||
| 2016-09-30 | -$4.64M 10-Q · filed 2017-11-07 | -$5.64M 10-Q · filed 2016-11-08 | -$10.47M derived: sum of 2 quarters · filed 2017-11-07 | -$17.48M 10-Q · filed 2017-11-07 | -$18.47M 10-Q · filed 2016-11-08 | -$22.45M derived: sum of 4 quarters · filed 2017-11-07 | ||||||||||||
| 2016-06-30 | -$5.83M 10-Q · filed 2017-08-14 | -$12.84M 10-Q · filed 2017-08-14 | -$17.80M derived: sum of 3 quarters · filed 2017-08-14 | -$23.96M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||||
| 2016-03-31 | -$7.01M 10-Q · filed 2017-05-15 | -$11.98M derived: sum of 2 quarters · filed 2017-05-15 | -$18.13M derived: sum of 3 quarters · filed 2017-05-15 | -$23.06M derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||||
| 2015-12-31 | -$4.97M 10-K · filed 2016-03-15 | -$11.12M derived: sum of 2 quarters · filed 2016-11-08 | -$16.05M derived: sum of 3 quarters · filed 2016-11-08 | -$21.12M 10-K · filed 2017-03-28 | ||||||||||||||
| 2015-09-30 | -$6.15M 10-Q · filed 2016-11-08 | -$11.08M derived: sum of 2 quarters · filed 2016-11-08 | -$16.16M 10-Q · filed 2016-11-08 | -$20.13M derived: sum of 4 quarters · filed 2016-11-08 | ||||||||||||||
| 2015-06-30 | -$4.93M 10-Q · filed 2016-08-09 | -$10.01M 10-Q · filed 2016-08-09 | -$13.97M derived: sum of 3 quarters · filed 2016-08-09 | -$17.83M derived: sum of 4 quarters · filed 2016-08-09 | ||||||||||||||
| 2015-03-31 | -$5.07M 10-Q · filed 2016-05-10 | -$9.04M derived: sum of 2 quarters · filed 2016-05-10 | -$12.89M derived: sum of 3 quarters · filed 2016-05-10 | -$16.63M derived: sum of 4 quarters · filed 2016-05-10 | ||||||||||||||
| 2014-12-31 | -$3.97M 10-K · filed 2016-03-15 | -$7.82M derived: sum of 2 quarters · filed 2016-03-15 | -$11.55M derived: sum of 3 quarters · filed 2016-03-15 | -$16.96M 10-K · filed 2016-03-15 | ||||||||||||||
| 2014-09-30 | -$3.85M 10-K · filed 2016-03-15 | -$7.58M derived: sum of 2 quarters · filed 2016-03-15 | -$12.99M 10-Q · filed 2015-11-09 | -$16.10M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-06-30 | -$3.73M 10-K · filed 2016-03-15 | -$9.14M 10-Q · filed 2015-08-10 | -$12.25M derived: sum of 3 quarters · filed 2016-03-15 | -$15.97M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-03-31 | -$5.41M 10-K · filed 2016-03-15 | -$8.52M derived: sum of 2 quarters · filed 2016-03-15 | -$12.24M derived: sum of 3 quarters · filed 2016-03-15 | -$23.88M derived: sum of 4 quarters · filed 2016-03-15 | -$107.63M 10-Q · filed 2014-05-13 | |||||||||||||
| 2013-12-31 | -$3.11M 10-K · filed 2015-03-18 | -$6.83M derived: sum of 2 quarters · filed 2015-03-18 | -$18.48M derived: sum of 3 quarters · filed 2015-03-18 | -$21.95M 10-K · filed 2016-03-15 | -$102.22M 10-K · filed 2014-03-21 | |||||||||||||
| 2013-09-30 | -$3.72M 10-K · filed 2015-03-18 | -$15.36M derived: sum of 2 quarters · filed 2015-03-18 | -$18.84M 10-Q · filed 2014-11-10 | -$21.54M derived: sum of 4 quarters · filed 2015-03-18 | -$99.11M 10-Q · filed 2013-11-12 | |||||||||||||
| 2013-06-30 | -$11.64M 10-K · filed 2015-03-18 | -$15.11M 10-Q · filed 2014-08-07 | -$17.82M derived: sum of 3 quarters · filed 2015-03-18 | -$20.81M derived: sum of 4 quarters · filed 2015-03-18 | -$95.39M 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | -$3.47M 10-K · filed 2015-03-18 | -$6.18M derived: sum of 2 quarters · filed 2015-03-18 | -$9.16M derived: sum of 3 quarters · filed 2015-03-18 | -$12.15M derived: sum of 4 quarters · filed 2015-03-18 | -$83.74M 10-Q · filed 2013-05-10 | |||||||||||||
| 2012-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | -$5.69M derived: sum of 2 quarters · filed 2015-03-18 | -$8.68M derived: sum of 3 quarters · filed 2015-03-18 | -$10.88M 10-K · filed 2015-03-18 | -$80.27M 10-K · filed 2013-03-29 | |||||||||||||
| 2012-09-30 | -$2.98M 10-Q · filed 2013-11-12 | -$5.97M derived: sum of 2 quarters · filed 2013-11-12 | -$8.17M 10-Q · filed 2013-11-12 | -$11.89M derived: sum of 4 quarters · filed 2013-11-12 | -$77.56M 10-Q · filed 2012-11-09 | |||||||||||||
| 2012-06-30 | -$2.98M 10-Q · filed 2013-08-14 | -$5.19M 10-Q · filed 2013-08-14 | -$8.91M derived: sum of 3 quarters · filed 2013-08-14 | -$11.24M derived: sum of 4 quarters · filed 2013-08-14 | -$74.58M 10-Q · filed 2012-08-10 | |||||||||||||
| 2012-03-31 | -$2.20M 10-Q · filed 2013-05-10 | -$5.92M derived: sum of 2 quarters · filed 2013-05-10 | -$8.26M derived: sum of 3 quarters · filed 2013-05-10 | -$12.20M derived: sum of 4 quarters · filed 2013-05-10 | -$71.59M 10-Q · filed 2012-05-11 | |||||||||||||
| 2011-12-31 | -$3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$6.06M derived: sum of 2 quarters · filed 2013-03-29 | -$9.99M derived: sum of 3 quarters · filed 2013-03-29 | -$12.71M 10-K · filed 2013-03-29 | -$69.39M 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | -$2.34M 10-Q · filed 2012-11-09 | -$6.27M derived: sum of 2 quarters · filed 2012-11-09 | -$8.99M 10-Q · filed 2012-11-09 | -$10.51M derived: sum of 4 quarters · filed 2012-11-09 | -$65.67M 10-Q · filed 2011-11-10 | |||||||||||||
| 2011-06-30 | -$3.93M 10-Q · filed 2012-08-10 | -$6.66M 10-Q · filed 2012-08-10 | -$8.17M derived: sum of 3 quarters · filed 2012-08-10 | -$10.07M derived: sum of 4 quarters · filed 2012-08-10 | -$63.33M 10-Q · filed 2011-08-12 | |||||||||||||
| 2011-03-31 | -$2.72M 10-Q · filed 2012-05-11 | -$4.24M derived: sum of 2 quarters · filed 2012-05-11 | -$6.14M derived: sum of 3 quarters · filed 2012-05-11 | -$8.61M derived: sum of 4 quarters · filed 2012-05-11 | ||||||||||||||
| 2010-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$3.42M derived: sum of 2 quarters · filed 2012-03-30 | -$5.89M derived: sum of 3 quarters · filed 2012-03-30 | -$8.71M 10-K · filed 2012-03-30 | ||||||||||||||
| 2010-09-30 | -$1.90M 10-Q · filed 2011-11-10 | -$4.37M derived: sum of 2 quarters · filed 2011-11-10 | -$7.19M 10-Q · filed 2011-11-10 | |||||||||||||||
| 2010-06-30 | -$2.48M 10-Q · filed 2011-08-12 | -$5.29M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |